Marzec KA - Search Results

1

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma.

Gonzalez Rajal A, Marzec KA, McCloy RA, Nobis M, Chin V, Hastings JF, Lai K, Kennerson M, Hughes WE, Vaghjiani V, Timpson P, Cain JE, Watkins DN, Croucher DR, Burgess A. Gonzalez Rajal A, et al. Among authors: marzec ka. Elife. 2021 May 13;10:e65234. doi: 10.7554/eLife.65234. Elife. 2021. PMID: 33983115 Free PMC article.

2

YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms.

Johnson TG, Schelch K, Lai K, Marzec KA, Kennerson M, Grusch M, Reid G, Burgess A. Johnson TG, et al. Among authors: marzec ka. Cancers (Basel). 2020 Aug 14;12(8):2285. doi: 10.3390/cancers12082285. Cancers (Basel). 2020. PMID: 32823952 Free PMC article.

3

SILAC kinase screen identifies potential MASTL substrates.

Marzec KA, Rogers S, McCloy R, Parker BL, James DE, Watkins DN, Burgess A. Marzec KA, et al. Sci Rep. 2022 Jun 22;12(1):10568. doi: 10.1038/s41598-022-14933-0. Sci Rep. 2022. PMID: 35732702 Free PMC article.

4

The Oncogenic Functions of MASTL Kinase.

Marzec K, Burgess A. Marzec K, et al. Front Cell Dev Biol. 2018 Nov 23;6:162. doi: 10.3389/fcell.2018.00162. eCollection 2018. Front Cell Dev Biol. 2018. PMID: 30555827 Free PMC article. Review.

5

SnapShot: S-Phase Entry and Exit.

Burgess A, Vuong J, Marzec KA, Nicolai de Lichtenberg U, O'Donoghue SI, Jensen LJ. Burgess A, et al. Among authors: marzec ka. Cell. 2019 Oct 17;179(3):802-802.e1. doi: 10.1016/j.cell.2019.09.031. Cell. 2019. PMID: 31626778 Free article.

6

The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents.

Lin MZ, Marzec KA, Martin JL, Baxter RC. Lin MZ, et al. Among authors: marzec ka. Oncogene. 2014 Jan 2;33(1):85-96. doi: 10.1038/onc.2012.538. Epub 2012 Nov 26. Oncogene. 2014. PMID: 23178489

7

BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.

Marzec KA, Martino-Echarri E, Irminger-Finger I, Henderson BR. Marzec KA, et al. Cancer Lett. 2016 Oct 10;381(1):149-55. doi: 10.1016/j.canlet.2016.07.034. Epub 2016 Jul 28. Cancer Lett. 2016. PMID: 27477900

8

Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast Cancer.

Marzec KA, Baxter RC, Martin JL. Marzec KA, et al. Biomed Res Int. 2015;2015:638526. doi: 10.1155/2015/638526. Epub 2015 Jun 28. Biomed Res Int. 2015. PMID: 26221601 Free PMC article. Review.

9

Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.

Marzec KA, Lin MZ, Martin JL, Baxter RC. Marzec KA, et al. Oncotarget. 2015 Sep 29;6(29):26583-98. doi: 10.18632/oncotarget.5612. Oncotarget. 2015. PMID: 26378048 Free PMC article.

10

The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.

Tembe V, Martino-Echarri E, Marzec KA, Mok MT, Brodie KM, Mills K, Lei Y, DeFazio A, Rizos H, Kettle E, Boadle R, Henderson BR. Tembe V, et al. Among authors: marzec ka. Cell Signal. 2015 Sep;27(9):1763-71. doi: 10.1016/j.cellsig.2015.05.011. Epub 2015 Jun 3. Cell Signal. 2015. PMID: 26022179

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page